Elantas Beck India [ELANTAS] vs Kansai Nerolac [KANSAINER] Detailed Stock Comparison

Elantas Beck India
BSE
Loading...

Kansai Nerolac
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Elantas Beck India wins in 8 metrics, Kansai Nerolac wins in 12 metrics, with 0 ties. Kansai Nerolac appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Elantas Beck India | Kansai Nerolac | Better |
---|---|---|---|
P/E Ratio (TTM) | 61.73 | 16.61 | Kansai Nerolac |
Price-to-Book Ratio | 8.78 | 2.93 | Kansai Nerolac |
Debt-to-Equity Ratio | 0.00 | 4.63 | Elantas Beck India |
PEG Ratio | 121.79 | -4.68 | Kansai Nerolac |
EV/EBITDA | 48.50 | 19.53 | Kansai Nerolac |
Profit Margin (TTM) | 16.56% | 14.43% | Elantas Beck India |
Operating Margin (TTM) | 16.43% | 11.57% | Elantas Beck India |
EBITDA Margin (TTM) | 16.43% | 11.57% | Elantas Beck India |
Return on Equity | 15.29% | 17.85% | Kansai Nerolac |
Return on Assets (TTM) | 8.41% | 13.91% | Kansai Nerolac |
Free Cash Flow (TTM) | $-819.18M | $3.46B | Kansai Nerolac |
Dividend Yield | 0.07% | 90.31% | Kansai Nerolac |
1-Year Return | -4.04% | -18.99% | Elantas Beck India |
Price-to-Sales Ratio (TTM) | 10.21 | 2.39 | Kansai Nerolac |
Enterprise Value | $75.97B | $169.72B | Kansai Nerolac |
EV/Revenue Ratio | 9.46 | 2.16 | Kansai Nerolac |
Gross Profit Margin (TTM) | 36.78% | 36.08% | Elantas Beck India |
Revenue per Share (TTM) | $1,013 | $97 | Elantas Beck India |
Earnings per Share (Diluted) | $167.45 | $14.00 | Elantas Beck India |
Beta (Stock Volatility) | 0.11 | 0.02 | Kansai Nerolac |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Elantas Beck India vs Kansai Nerolac Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Elantas Beck India | 1.90% | -4.51% | -20.99% | 17.50% | 10.90% | -15.01% |
Kansai Nerolac | -0.79% | -1.57% | -3.09% | -8.38% | 1.92% | -9.66% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Elantas Beck India | -4.04% | 158.47% | 316.96% | 697.31% | 1,414.62% | 2,661.98% |
Kansai Nerolac | -18.99% | -53.53% | -50.62% | -0.31% | 184.39% | 634.21% |
Performance & Financial Health Analysis: Elantas Beck India vs Kansai Nerolac
Metric | ELANTAS | KANSAINER |
---|---|---|
Market Information | ||
Market Cap | ₹81.95B | ₹187.98B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 577 | 243,654 |
90 Day Avg. Volume | 724 | 193,334 |
Last Close | ₹11,045.85 | ₹236.48 |
52 Week Range | ₹8,149.95 - ₹14,980.00 | ₹218.20 - ₹320.50 |
% from 52W High | -26.26% | -26.22% |
All-Time High | ₹14,980.00 (Oct 14, 2024) | ₹680.00 (Jan 18, 2021) |
% from All-Time High | -26.26% | -65.22% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.10% | 0.01% |
Quarterly Earnings Growth | -0.06% | -0.04% |
Financial Health | ||
Profit Margin (TTM) | 0.17% | 0.14% |
Operating Margin (TTM) | 0.16% | 0.12% |
Return on Equity (TTM) | 0.15% | 0.18% |
Debt to Equity (MRQ) | 0.00 | 4.63 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹1,177.04 | ₹79.45 |
Cash per Share (MRQ) | ₹752.73 | ₹26.39 |
Operating Cash Flow (TTM) | ₹702.99M | ₹14.19B |
Levered Free Cash Flow (TTM) | ₹-290,126,496 | ₹11.43B |
Dividends | ||
Last 12-Month Dividend Yield | 0.07% | 90.31% |
Last 12-Month Dividend | ₹7.50 | ₹215.75 |
Valuation & Enterprise Metrics Analysis: Elantas Beck India vs Kansai Nerolac
Metric | ELANTAS | KANSAINER |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 61.73 | 16.61 |
Forward P/E | 121.79 | 24.11 |
PEG Ratio | 121.79 | -4.68 |
Price to Sales (TTM) | 10.21 | 2.39 |
Price to Book (MRQ) | 8.78 | 2.93 |
Market Capitalization | ||
Market Capitalization | ₹81.95B | ₹187.98B |
Enterprise Value | ₹75.97B | ₹169.72B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 9.46 | 2.16 |
Enterprise to EBITDA | 48.50 | 19.53 |
Risk & Other Metrics | ||
Beta | 0.11 | 0.02 |
Book Value per Share (MRQ) | ₹1,177.04 | ₹79.45 |
Financial Statements Comparison: Elantas Beck India vs Kansai Nerolac
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ELANTAS | KANSAINER |
---|---|---|
Revenue/Sales | ₹2.10B | ₹21.62B |
Cost of Goods Sold | ₹1.33B | ₹13.82B |
Gross Profit | ₹772.21M | ₹7.80B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹345.02M | ₹2.50B |
EBITDA | ₹580.99M | ₹3.56B |
Pre-Tax Income | ₹528.43M | ₹2.95B |
Income Tax | ₹135.56M | ₹798.70M |
Net Income (Profit) | ₹392.88M | ₹2.16B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ELANTAS | KANSAINER |
---|---|---|
Cash & Equivalents | ₹1.40B | ₹940.00M |
Total Current Assets | ₹7.71B | ₹53.52B |
Total Current Liabilities | ₹1.23B | ₹14.51B |
Long-Term Debt | N/A | ₹1.75B |
Total Shareholders Equity | ₹8.67B | ₹64.04B |
Retained Earnings | ₹7.90B | ₹58.42B |
Property, Plant & Equipment | ₹1.46B | ₹837.10M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ELANTAS | KANSAINER |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ELANTAS | KANSAINER |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 577 | 243,654 |
Average Daily Volume (90 Day) | 724 | 193,334 |
Shares Outstanding | 7.93M | 808.44M |
Float Shares | 1.86M | 201.21M |
% Held by Insiders | 0.76% | 0.75% |
% Held by Institutions | 0.12% | 0.11% |
Dividend Analysis & Yield Comparison: Elantas Beck India vs Kansai Nerolac
Metric | ELANTAS | KANSAINER |
---|---|---|
Last 12-Month Dividend | ₹7.50 | ₹215.75 |
Last 12-Month Dividend Yield | 0.07% | 90.31% |
3-Year Avg Annual Dividend | ₹5.83 | ₹72.73 |
3-Year Avg Dividend Yield | 0.07% | 29.65% |
3-Year Total Dividends | ₹17.50 | ₹218.20 |
Ex-Dividend Date | Apr 23, 2025 | Jun 23, 2025 |